We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Director dealings: New Afentra appointee invests, Dunelm insider covers tax bill

Tue 11 November 2025 15:22 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Two London-listed companies, Afentra and Dunelm Group, were among those reporting director and senior management share transactions on Tuesday, following recent board and market developments at both firms.

Afentra, the AIM-listed upstream oil and gas company focused on West Africa, reported that Acorn Investment Management, a person closely associated with newly appointed non-executive director Andrew Osborne, purchased 225,000 ordinary shares in the company at an average price of 47.11p per share.

The transaction, valued at around 106,000, was made on 10 November.

It followed Afentra's announcement on Monday of Osborne's appointment as an independent non-executive director and chair of the audit committee.

Afentra said Osborne, a former Harbour Energy executive, was bringing more than three decades of senior leadership experience in oil and gas, capital markets, and mergers and acquisitions.

His addition to the board was welcomed by Afentra chairman Thierry Tanoh, who highlighted Osborne's "deep financial, transaction and governance experience" as enhancing the company's oversight and capital discipline.

Separately, homeware retailer Dunelm Group disclosed that group general counsel and company secretary Luisa Wright exercised 4,787 nil-cost options under the company's long-term incentive plan, and subsequently sold 2,257 shares at 1,121p each to cover tax and National Insurance liabilities arising from the exercise.

Both transactions took place on 10 November, with the sale conducted on the London Stock Exchange.

The disclosure came as Dunelm's shares recovered from a recent drop following an upgrade last week from RBC Capital Markets, which lifted its rating to "outperform" and raised its price target to 1,300p.

At the time, the bank cited stronger gross margin momentum, robust cash generation and expanding market share as reasons for its improved outlook.

RBC forecast 2026 revenue growth of just over 5%, and said it saw potential for further shareholder returns, including a special dividend early next year.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 100,000 @ 1,616.00p

Value: 1,615,999.98

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 100,000 @ 1,605.00p

Value: 1,604,999.92

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 100,000 @ 1,592.00p

Value: 1,592,000.01

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 100,000 @ 1,525.00p

Value: 1,525,000.00

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 70,000 @ 1,541.00p

Value: 1,078,699.99

Hikma Pharmaceuticals (HIK)

Director name: Darwazah,Said

Amount purchased: 60,000 @ 1,589.00p

Value: 953,400.02

Metlen Energy & Metals (MTLN)

Director name: Mytilineos,Evangelos

Amount purchased: 10,000 @ 42.15

Value: 421,525.00

Afentra (AET)

Director name: Osborne,Andrew

Amount purchased: 225,000 @ 47.11p

Value: 105,995.92

Mercantile Investment Trust (the) (MRC)

Director name: Beagles,Rachel

Amount purchased: 30,000 @ 246.73p

Value: 74,019.00

Mercantile Investment Trust (the) (MRC)

Director name: Beagles,Rachel

Amount purchased: 10,771 @ 247.04p

Value: 26,608.45

Hays (HAS)

Director name: Kirby,Anthony

Amount purchased: 10,000 @ 58.28p

Value: 5,827.91

F&c Investment Trust (FCIT)

Director name: Smith,Rain Newton

Amount purchased: 81 @ 1,217.96p

Value: 986.55

F&c Investment Trust (FCIT)

Director name: Hollond,Beatrice

Amount purchased: 81 @ 1,217.96p

Value: 986.55

Judges Scientific (JDG)

Director name: Ormsby,Bradley Leonard

Amount purchased: 3 @ 5,540.00p

Value: 166.20

Judges Scientific (JDG)

Director name: Cicurel,David

Amount purchased: 3 @ 5,540.00p

Value: 166.20

Taylor Wimpey (TW.)

Director name: Daly,Jennie

Amount purchased: 142 @ 105.49p

Value: 149.80

Taylor Wimpey (TW.)

Director name: Carney,Chris

Amount purchased: 142 @ 105.49p

Value: 149.80

Spectris (SXS)

Director name: Noon,Angela

Amount purchased: 3 @ 4,108.67p

Value: 123.26

Spectris (SXS)

Director name: Heath ,Andrew

Amount purchased: 3 @ 4,108.67p

Value: 123.26

Spectris (SXS)

Director name: Harding ,Derek

Amount purchased: 3 @ 4,108.67p

Value: 123.26

Top Director Sells

Dunelm Group (DNLM)

Director name: Wright,Luisa

Amount sold: 2,257 @ 1,121.00p

Value: 25,300.97

Staffline Group (STAF)

Director name: Spain,Thomas

Amount sold: 43,036 @ 45.50p

Value: 19,581.38

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.